Sleep abnormalities are widely reported in patients with Alzheimer's disease (AD) and are
linked to cognitive impairments. Sleep abnormalities could be potential biomarkers to detect …

Sleep problems relate to brain changes in aging and disease, but the mechanisms are
unknown. Studies suggest a relationship between β-amyloid (Aβ) accumulation and sleep …

See Mander et al.(doi: 10.1093/awx174) for a scientific commentary on this article. Sleep
deprivation increases amyloid-β, suggesting that chronically disrupted sleep may promote …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with
cognitive impairment in older adults. The accumulation of insoluble forms of amyloid-b (Ab) …

Sleep disorders are prevalent in Alzheimer's disease (AD) and a major cause of
institutionalization. Like AD pathology, sleep abnormalities can appear years before …

Chronic short sleep (CSS) is prevalent in modern societies and has been proposed as a risk
factor for Alzheimer's disease (AD). In support, short-term sleep loss acutely increases levels …

Amyloid-β (Aβ) accumulation is a hallmark of Alzheimer's disease, although Aβ alone may
be insufficient to cause impairments. Modifiable health factors, including sleep, may mitigate …

Chronic sleep insufficiency is becoming a common issue in the young population nowadays,
mostly due to life habits and work stress. Studies in animal models of neurological diseases …

As we age, sleep patterns undergo significant modifications in micro and macrostructure,
worsening cognition and quality of life. These are associated with remarkable brain …

Sleep disruption appears to be a core component of Alzheimer's disease (AD) and its
pathophysiology. Signature abnormalities of sleep emerge before clinical onset of AD …